Wu W, Wang H-D, Zhu X-X, Lan G, Yang K
Department of Cardiothoracic Surgery, Southwest Hospital, Third Military Medical University, 30 Gaotanyan St, Shapingba District, Chongqing 400038, China.
Transplant Proc. 2009 Dec;41(10):4321-7. doi: 10.1016/j.transproceed.2009.08.062.
Activation of the complement system is the leading mechanism that causes antibody-mediated acute rejection and hyperacute rejection after xenotransplantation. The major cause of acute rejection in allogeneic transplantation is the T cell-mediated specific immune response. We studied the effects of complement on acute rejection after cardiac allotransplantation using complement depletion with cobra venom factor (CVF) in the mouse.
The Balb/c-C57 mouse model of heterotopic cardiac allograft was used. The mice were divided into 2 groups, a control group and a CVF-treated group. After intravenous injection of CVF, the experimental group was observed for allograft survival time. Twelve mice from the control and experimental groups were sacrificed on days 3, 5, and 7 after the operation. The pathologic grade of acute rejection, deposition of C3 in tissue, extent of infiltration by CD4+ and CD8+ T cells, and expression of MHC-II, B7-1, and B7-2 were compared between the 2 groups.
In the CVF-treated group, mean (SD) survival of the cardiac allograft was 26.2 (1.7) days, and in the control group was 8.4 (0.4) days (P < .01). Pathologic examination and immunohistochemistry demonstrated that the grade of acute rejection, deposition of C3 in tissue, extent of infiltration of CD4+ and CD8+ T cells, and expression of MHC-II, B7-1, and B7-2 were significantly decreased in the CVF-treated group.
Depletion of complement in the serum with CVF inhibits acute cardiac allograft rejection in the mouse.
补体系统的激活是异种移植后导致抗体介导的急性排斥和超急性排斥的主要机制。同种异体移植中急性排斥的主要原因是T细胞介导的特异性免疫反应。我们使用眼镜蛇毒因子(CVF)消耗补体,研究补体对小鼠心脏同种异体移植后急性排斥的影响。
采用Balb/c-C57小鼠异位心脏同种异体移植模型。将小鼠分为2组,对照组和CVF治疗组。静脉注射CVF后,观察实验组同种异体移植物的存活时间。在术后第3、5和7天,处死对照组和实验组的12只小鼠。比较两组急性排斥的病理分级、组织中C3的沉积、CD4+和CD8+T细胞的浸润程度以及MHC-II、B7-1和B7-2的表达。
在CVF治疗组中,心脏同种异体移植物的平均(标准差)存活时间为26.2(1.7)天,对照组为8.4(0.4)天(P <.01)。病理检查和免疫组织化学表明,CVF治疗组急性排斥的分级、组织中C3的沉积、CD4+和CD8+T细胞的浸润程度以及MHC-II、B7-1和B7-2的表达均显著降低。
用CVF消耗血清中的补体可抑制小鼠心脏同种异体移植的急性排斥反应。